Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.7K
Scalar Product (Dot Product)01:11

Scalar Product (Dot Product)

27.4K
The scalar multiplication of two vectors is known as the scalar or dot product. As the name indicates, the scalar product of two vectors results in a number, that is, a scalar quantity. Scalar products are used to define work and energy relations. For example, the work that a force (a vector) performs on an object while causing its displacement (a vector) is defined as a scalar product of the force vector with the displacement vector.
The scalar product of two vectors is obtained by multiplying...
27.4K
Vector Product (Cross Product)01:17

Vector Product (Cross Product)

27.9K
Vector multiplication of two vectors yields a vector product, with the magnitude equal to the product of the individual vectors multiplied by the sine of the angle between both the vectors and the direction perpendicular to both the individual vectors. As there are always two directions perpendicular to a given plane, one on each side, the direction of the vector product is governed by the right-hand thumb rule.
Consider the cross product of two vectors. Imagine rotating the first vector about...
27.9K
Primary Production01:06

Primary Production

25.3K
The total amount of energy acquired by primary producers in an ecosystem is called gross primary production (GPP). However, of this energy, producers use some for metabolic processes, and some is lost as heat, decreasing the amount of energy available to the next trophic level. The remaining usable amount of energy is called the net primary productivity (NPP). In terrestrial ecosystems, NPP is driven by climate, while light penetration and nutrient availability drive NPP in aquatic ecosystems.
25.3K
Production Efficiency01:01

Production Efficiency

18.3K
Net production efficiency (NPE) is the efficiency at which organisms assimilate energy into biomass for the next trophic level. Due to low metabolic rates and less energy spent on thermoregulatory processes, the NPE of ectotherms (cold-blooded animals) is 10 times higher than endotherms (warm-blooded animals).
18.3K
The Dot Product01:26

The Dot Product

263
Measuring how one directional quantity affects another along a specific path involves comparing their orientation and strength. When two such quantities are represented using direction and amount, a numerical result is computed to show how much one acts along the path of the other. This result comes from a rule combining both inputs' horizontal and vertical parts and adding the results.This calculation gives a single value that grows larger when both inputs point in similar directions and...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemodynamic management, including for left ventricular outflow tract obstruction, in an infant with ACTH-independent Cushing syndrome undergoing adrenal tumor removal: a case report.

JA clinical reports·2026
Same author

The PROMISE-ACHD Score: Prediction of Perioperative Mortality and Major Morbidity in Adult Congenital Heart Disease.

JACC. Advances·2026
Same author

Successful Management of Total Intravenous Anesthesia Using Remimazolam, Dexmedetomidine, and Remifentanil for Airway Stenting Under Rigid Bronchoscopy: A Case Report.

Clinical case reports·2026
Same author

Endogenously generated Dutch-type Aβ non-fibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Effects of ethanol exposure in neonatal mice on retinoic acid signaling in forebrain neurons and astrocytes.

IBRO neuroscience reports·2026
Same author

Psychometric criteria for superior cognitive performance in very old adults.

Journal of Alzheimer's disease : JAD·2026

Related Experiment Video

Updated: Feb 1, 2026

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
10:59

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases

Published on: November 18, 2013

18.8K

Apolipoprotein E4 genotype compromises brain exosome production.

Katherine Y Peng1,2, Rocío Pérez-González2, Melissa J Alldred2,3

  • 1Department of Neurology, New York University Langone Health, New York, NY, USA.

Brain : a Journal of Neurology
|November 30, 2018
PubMed
Summary

The apolipoprotein E4 (APOE4) genotype reduces brain exosome levels, impacting cellular waste removal and increasing Alzheimer's disease risk. This dysfunction occurs before other endosomal changes, highlighting its primary role in APOE4-related brain pathology.

More Related Videos

Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
09:51

Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons

Published on: January 29, 2015

16.8K
Genotyping of Plant and Animal Samples without Prior DNA Purification
11:00

Genotyping of Plant and Animal Samples without Prior DNA Purification

Published on: September 24, 2012

31.8K

Related Experiment Videos

Last Updated: Feb 1, 2026

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
10:59

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases

Published on: November 18, 2013

18.8K
Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
09:51

Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons

Published on: January 29, 2015

16.8K
Genotyping of Plant and Animal Samples without Prior DNA Purification
11:00

Genotyping of Plant and Animal Samples without Prior DNA Purification

Published on: September 24, 2012

31.8K

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Apolipoprotein E4 (APOE4) is the primary genetic risk factor for Alzheimer's disease (AD).
  • APOE4 expression can cause age-related cognitive decline independent of amyloid-β and tau pathology.
  • Brain exosomes are crucial vesicles involved in intercellular communication and waste removal.

Purpose of the Study:

  • To investigate the impact of APOE4 on brain exosome production and levels.
  • To determine if APOE4-associated exosome changes are linked to age and other brain pathologies.
  • To elucidate the role of exosome pathway dysfunction in APOE4-driven neurodegeneration.

Main Methods:

  • Analysis of human post-mortem brain tissue.
  • Examination of mouse models humanized for human APOE isoforms.
  • Quantification of brain exosome levels and expression of exosome pathway regulators (TSG101, RAB35) at protein and mRNA levels.
  • Age-dependent analysis of exosome levels in APOE4 mice.

Main Results:

  • APOE4 genotype, whether homozygous or heterozygous, leads to reduced brain exosome levels compared to APOE3.
  • This reduction in exosome levels is age-dependent in mice, becoming significant by 12 months of age.
  • Expression of exosome biogenesis regulators (TSG101, RAB35) is downregulated in the brains of APOE4 carriers.
  • Compromised exosome production precedes other observed endosomal-lysosomal deficits in APOE4 models.

Conclusions:

  • APOE4 genotype dysregulates exosome biosynthesis and release in the brain.
  • Exosome pathway dysfunction is an early and potentially primary contributor to endosomal-lysosomal deficits in APOE4 brains.
  • Disruption of the endosomal-exosomal-lysosomal system due to APOE4 may drive neurodegenerative processes, increasing Alzheimer's disease vulnerability.